Skip to main content

CHOP Omics Initiative News

Omics helps us get closer to more precise treatments for every patient. Learn what omics means and how we’re revolutionizing the future of pediatric medicine. 

In the Journals: Nirsevimab

Jan 18, 2024

Find out about the results of a prospective, placebo-controlled trial in 8,058 healthy infants that served as the basis for licensure of nirsevimab.

Jump back to top